Skip to main content
. 2016 Aug 17;16:644. doi: 10.1186/s12885-016-2709-z

Fig. 1.

Fig. 1

Evofosfamide decreases the hypoxic fraction in a Rhabdomyosarcoma rat model. PET-scans with hypoxia tracer 18F-HX4 were made before (day 0) and after (day 4) administering evofosfamide for four consecutive days at a dose of 25 mg/kg